TCL Archive Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study December 26, 2014
TCL Archive In Brief: No Intention Of Cutting Back On Cancer, Heart Research, Weinberger Spokesman Insists June 7, 1974